Community response to repeated annual ivermectin treatment of onchocerciasis in nigeria

Parasitology Research

Volumn 88, Issue 7, 2002, Pages 704-707

  Oyibo, W ^a   Fagbenro Beyioku, A ^b  

^a Medicare Program for Africa   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; ANTHELMINTIC AGENT;

ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; ENDEMIC DISEASE; FEEDBACK SYSTEM; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MOBILIZATION; NIGERIA; ONCHOCERCIASIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; ATTITUDE TO HEALTH; GEOGRAPHY;

LILE; NEMATODA;

ANTHELMINTICS; ATTITUDE TO HEALTH; GEOGRAPHY; HUMANS; IVERMECTIN; NIGERIA; ONCHOCERCIASIS; PATIENT COMPLIANCE;

EID: 0036092842     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-001-0579-y     Document Type: Article

References (23)

1. The impact of five years of annual ivermectin treatment in skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana
2. Community-based distribution of ivermectin in eastern Sudan: Acceptability and early post-treatment reactions
3. Ivermectin treatment in severe asymmetric reactive onchodermatitis (Sowda) in Sudan
4. Changes in visual function and in posterior segment of the eye during treatment of onchocerciasis with diethyl-carbamazine
5. The impact of Mectizan treatment on the transmission of onchocerciasis
6. Detection methods and strategy for improving medication compliance
7. Effects of repeated treatments with ivermectin on incidence of onchocerciasis in northern Cameroon
8. Onchocerca volvulus striking decrease in transmission in the Vina Valley (Cameroon) after eight annual large-scale ivermectin treatments
9. Changes in the user profile of mectizan: 1987-1997
10. Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi
11. Ivermectin: Reduction in prevalence and infection intensity of Onchocerca volvulus following bi-annual treatments in five Guatemalan communities
12. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: Combined results from eight community trials
13. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis
14. Successful control of onchocerciasis with community-based ivermectin distribution in the Rio Santiago focus in Ecuador
15. Community treatment with ivermectin for onchocerciasis in the East Usambara Mountains
16. Evaluation of community compliance with annual ivermectin treatment in Patigi, Nigeria
17. Community-based treatment of onchocerciasis with ivermectin: Acceptability and early adverse reactions
18. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the onchocerciasis control programme in West Africa
19. Side-effects of ivermectin in the treatment of onchocerciasis
20. The status of ivermectin in the control of onchocerciasis
21. Controlled clinical trial of oral and topical diethylcarbamazine in the treatment of onchocerciasis
22. Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala